PodBrowser
This Week Startups

With other cultivated meat companies are collapsing, this one turned a profit | E2317

Monday, 27 July 2026 · 3 min read · Listen to the episode ↗

Integrity Culture, a Japanese cell agriculture company, reached profitability by selling cell-cultured cosmetic ingredients rather than waiting for cultivated meat regulation to mature, using that revenue to fund its core meat technology. Its flagship food product, Kraft Essen, uses cultured duck liver cells grown on scaffolds, and Japan's consumer agency is expected to grant broader cultivated meat regulatory approval by late summer.

Integrity Culture, a Japanese cell agriculture company, turned profitable last year by entering the cosmetics market rather than waiting for cultivated meat regulation and technology to mature. The company sells cell-cultured cosmetic ingredients that address ethical, safety, and supply chain problems tied to conventional placenta-based beauty products, and the cultured version is slightly cheaper than the stem cell serum currently imported from Korea. This cosmetics revenue stream funds the core meat technology while it develops. Total funding raised is between 15 and 20 million USD, with a seed round closed in 2018 from Japanese venture capital firms and government-backed sovereign funds.

The company's flagship food product is a trademarked item called Kraft Essen, made from cell-cultured duck liver cells grown on scaffolds using the same cells as foie gras. Integrity Culture is deliberately not marketing it as foie gras due to niche market positioning concerns. Japan's consumer agency has already held hearing sessions with consumer groups, and the company expects regulatory approval for broader cultivated meat sales in supermarkets and restaurants by end of summer or early autumn. Singapore has already granted some regulatory clearance for cultivated meat products, while US bans in states like Florida and Texas have become entangled in culture war politics rather than being evaluated on product merit.

Founder Yuki Hanyu identified scaling and unit economics as the core reasons cultivated meat has not gone mainstream, and noted that without sufficient quantity at scale, real consumer demand cannot be properly tested. Current state-of-the-art cultivated meat is produced as a slurry of cells in large stirred-tank bioreactors rather than structured muscle tissue, and the lack of fiber and texture limits imitation completeness to approximately 70 percent at maximum. Fetal bovine serum is not viable for commercial production due to cost and variable chemical composition. The biopharma industry is moving toward chemically defined media as an alternative, but those remain very expensive.

Integrity Culture grew out of the Chose Meet Project, an open source DIY cell cultured meat initiative that began in 2014 and is still ongoing, with potentially thousands of participants including school programs. The company structured itself as part of a three-entity ecosystem combining an open source community, a nonprofit for regulatory and academic engagement, and a for-profit entity for physical infrastructure and proprietary scaling. This structure was chosen specifically to prevent cell cultured meat from becoming politically polarized the way GMOs did. The company intends to offer contract manufacturing so hobbyists who develop novel cell cultured products can scale through its infrastructure.

Cultivated meat currently represents approximately 0.001 percent or less of the existing meat industry by scale, and the industry is described as being in a stunt phase before reaching niche and then mainstream adoption. Premium cultivated wagyu and high-end beef could reach price parity with conventional equivalents in approximately ten years, as conventional meat prices have historically doubled roughly every decade. Commodity chicken at scale would require a decade or two and technology not yet available. Building large-scale factories, even once the technology is ready, takes many years comparable to constructing a nuclear power station, and price parity depends heavily on branding as much as on the underlying product.

Yuki argued that cultivated meat will likely form its own separate category rather than fitting into the existing hierarchy of traditional meat products, partly because conventional meat brand owners do not want cell-cultured versions competing in their established market segments. Japan's Ministry of Agriculture, Forestry and Fishery has taken a formal position consistent with this view, officially avoiding the term meat when referring to cell culture food products. A commodity cultivated meat hamburger is described as the holy grail product for the industry, but Yuki estimated it could take roughly ten years to reach price parity with conventional beef and acknowledged that claims about cultivated meat reaching mainstream consumers remain speculative given the current stage of development.

This summary was generated from the episode transcript and can contain mistakes.